Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details 5)

v3.19.1
Stockholders' Equity (Details 5) - Common Stock Warrants [Member] - $ / shares
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Outstanding at beginning 8,949,078 1,991,293
Issued 7,134,200
Exercised (221,773) (8,207)
Terminated (50,824) (168,208)
Outstanding at ending 8,676,481 8,949,078
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price [Roll Forward]    
Outstanding at beginning $ 4.12 [1] $ 13.00
Issued 2.20
Exercised 2.15 2.00
Terminated 6.64 17.64
Outstanding at ending $ 4.17 $ 4.12 [1]
[1] The weighted-average exercise price reflects exercise price adjustments triggered by the 2017 PIPE.